Ghent University Academic Bibliography

Show Sort by

Your filters: cql: author exact 801000944391 cql: author exact 870110704547

Mark
Influence of chemotherapy on the biodistribution of [99mTc]hydrazinonicotinamide annexin V in cancer patients

Sylvie Rottey (UGent) , BIEKE VAN DEN BOSSCHE (UGent) , G Slegers, Simon Van Belle (UGent) and Christophe Van De Wiele (UGent)

(2009) QUARTERLY JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING. 53(2). p.127-132
Mark
- journalArticle
- A1
Early prediction of endocrine therapy effect in advanced breast cancer patients using Tc-99m-depreotide scintigraphy

BIEKE VAN DEN BOSSCHE (UGent) , Simon Van Belle (UGent) , F DE WINTER, A SIGNORE and Christophe Van De Wiele (UGent)

(2006) JOURNAL OF NUCLEAR MEDICINE. 47(1). p.6-13
Mark
- journalArticle
- A1
Oestrogen-mediated regulation of somatostatin receptor expression in human breast cancer cell lines assessed with Tc-99m-depreotide

BIEKE VAN DEN BOSSCHE (UGent) , E D'HAENINCK, Filip De Vos (UGent) , Rudi Dierckx (UGent) , Simon Van Belle (UGent) , Marc Bracke (UGent) and Christophe Van De Wiele (UGent)

(2004) EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING. 31(7). p.1022-1030
Mark
- journalArticle
- A1
Biodistribution and dosimetry of Tc-99m-depreotide (P829) in patients suffering from breast carcinoma

BIEKE VAN DEN BOSSCHE (UGent) , E D'HAENINCK, Klaus Bacher (UGent) , Hubert Thierens (UGent) , Simon Van Belle (UGent) , Rudi Dierckx (UGent) and Christophe Van De Wiele (UGent)

(2004) CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS. 19(6). p.776-783
Mark
- journalArticle
- A1
Tc-99m depreotide scan compared with Tc-99m-MDP bone scintigraphy for the detection of bone metastases and prediction of response to hormonal treatment in patients with breast cancer

BIEKE VAN DEN BOSSCHE (UGent) , E D'HAENINCK, F DE WINTER, Simon Van Belle (UGent) , Rudi Dierckx (UGent) and Christophe Van De Wiele (UGent)

(2004) NUCLEAR MEDICINE COMMUNICATIONS. 25(8). p.787-792
Mark
- journalArticle
- A1
Biodistribution and dosimetry study of I-123-rh-annexin V in mice and humans

CMM LAHORTE, Christophe Van De Wiele (UGent) , Klaus Bacher (UGent) , BIEKE VAN DEN BOSSCHE (UGent) , Hubert Thierens (UGent) , Simon Van Belle (UGent) , G SLEGERS and Rudi Dierckx (UGent)

(2003) NUCLEAR MEDICINE COMMUNICATIONS. 24(8). p.871-880

Academic Bibliography

Influence of chemotherapy on the biodistribution of [99mTc]hydrazinonicotinamide annexin V in cancer patients

Early prediction of endocrine therapy effect in advanced breast cancer patients using Tc-99m-depreotide scintigraphy

Oestrogen-mediated regulation of somatostatin receptor expression in human breast cancer cell lines assessed with Tc-99m-depreotide

Biodistribution and dosimetry of Tc-99m-depreotide (P829) in patients suffering from breast carcinoma

Tc-99m depreotide scan compared with Tc-99m-MDP bone scintigraphy for the detection of bone metastases and prediction of response to hormonal treatment in patients with breast cancer

Biodistribution and dosimetry study of I-123-rh-annexin V in mice and humans

Contents

Support

Contact